UT Southwestern Medical Center - Redbird — Dallas, Texas

UT Southwestern Medical Center - Redbird is a clinical research site located in Dallas, Texas, United States 75237.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

UT Southwestern Medical Center - Redbird has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dallas

Browse all research sites in Texas · View every site in Dallas

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UT Southwestern Medical Center - Redbird?

UT Southwestern Medical Center - Redbird has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UT Southwestern Medical Center - Redbird conducted?

UT Southwestern Medical Center - Redbird has 2 clinical trials on record, with 2 currently active. Their work covers Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma.

Is UT Southwestern Medical Center - Redbird accredited by Crixeo Clinical Trials?

UT Southwestern Medical Center - Redbird has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UT Southwestern Medical Center - Redbird?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.